Study tumor metabolism in certain types of breast cancer surgery
Part of Cancer, Skin clinical trials.
This study looks at how breast cancer cells use energy and nutrients in hormone-receptor positive, HER2-negative tumors during planned surgery. It may help researchers understand the cancer better by comparing tumor tissue with nearby normal tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your breast cancer is hormone-receptor positive and HER2 negative (ER and/or PR positive, but not HER2+).
- Your cancer stage is early (stage I, II, or III).
- You are planning curative surgery (tumor removal) and you have NOT had neoadjuvant treatment before surgery (no chemo, immunotherapy, or hormone therapy before the operation).
- You can safely provide extra small tissue samples during surgery (small biopsies of tumor and normal tissue, typically 4–6 passes).
- You are not in another research study that gives treatments during the same time period.
- If you could become pregnant, you can provide a recent negative pregnancy test done outside of this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at different drug combinations given before surgery to shrink breast tumors. The goal is to find which treatments work best for different types of breast cancer, such as triple-negative, HER2-positive, or hormone-receptor-positive. If you are a woman scheduled for neoadjuvant therapy (treatment before surgery) and have not had previous cancer treatment, this study may be for you.
This Phase 2 study looks at how well early breast cancer shrinks with treatment and how that matches with what doctors find after surgery under the microscope. The goal is to learn better ways to predict and assess treatment success.
This study tests different treatment plans given before surgery for early breast cancer that is both hormone receptor-positive and HER2-positive. The goal is to see which treatment is more effective and to tailor it to each patient.
This study tests personalized, changing treatment plans (given before surgery) to find better options for your specific breast tumor. You may be asked for extra breast-tissue testing to help match you with the most suitable study drug(s).
This study looks at how breast cancer changes while you are receiving chemotherapy or targeted therapy before surgery. The goal is to better understand which treatments work best for different types of breast cancer.
This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.